$8.25 -1.7 -17.3%
Last Trade - 19/04/21
| Market Cap | £152.9m |
| Enterprise Value | £145.3m |
| Revenue | £26.7m |
| Position in Universe | 4445th / 6849 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.22 | 5.24 | 3.68 | 8.32 | 12.5 | 37.3 | 86.1 | 119.8 | +98.2% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
LifeMD Inc, formerly Conversion Labs, Inc., is a consumer telemedicine and wellness company. The Company builds technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications to patients. The Company’s brands include Shapiro MD and Rex MD. The Shapiro MD is a hair loss treatment line that consists of patented over-the-counter products and Food and Drug Administration (FDA) approved prescription medications. Its products are sold to consumers based on their individual hair loss needs and objectives. Its customers can purchase over the counter products from its Website and can receive a free consultation with a physician and have prescription medications sent to their home. Its Rex MD is an online healthcare clinic for men. The Company provides virtual consultations with physicians to deliver prescription medications for erectile dysfunction.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | June 21, 1994 |
| Public Since | July 11, 2001 |
| No. of Shareholders: | n/a |
| No. of Employees: | 3 |
| Sector | Consumer Cyclicals |
| Industry | Diversified Retail |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | 25,906,754 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 800 Third Avenue Suite 2800, NEW YORK, 10022, United States |
| Web | https://lifemd.com/ |
| Phone | +1 914 2441777 |
| Contact | Ron Both (Investor Relations) |
| Auditors | Friedman LLP |
As of 19/04/21, shares in LifeMD Inc are trading at $8.25, giving the company a market capitalisation of £152.9m. This share price information is delayed by 15 minutes.
Shares in LifeMD Inc are currently trading at $8.25 and the price has moved by 0.489k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the LifeMD Inc price has moved by 0.297k% over the past year.
There are no analysts currently covering LifeMD Inc.
LifeMD Inc is scheduled to issue upcoming financial results on the following dates:
LifeMD Inc does not currently pay a dividend.
LifeMD Inc does not currently pay a dividend.
LifeMD Inc does not currently pay a dividend.
To buy shares in LifeMD Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in LifeMD Inc are currently trading at $8.25, giving the company a market capitalisation of £152.9m.
Here are the trading details for LifeMD Inc:
Based on an overall assessment of its quality, value and momentum, LifeMD Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in LifeMD Inc are currently priced at $8.25. At that level they are trading at 0.355% discount to the analyst consensus target price of 0.00.
Analysts covering LifeMD Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.59 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LifeMD Inc. Over the past six months, the relative strength of its shares against the market has been 13.26%. At the current price of $8.25, shares in LifeMD Inc are trading at -20.29% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for LifeMD Inc.
LifeMD Inc's management team is headed by:
Here are the top five shareholders of LifeMD Inc based on the size of their shareholding:
